151 related articles for article (PubMed ID: 9330696)
1. HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.
Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
Adv Exp Med Biol; 1997; 421():185-92. PubMed ID: 9330696
[TBL] [Abstract][Full Text] [Related]
2. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
J Immunol; 1997 Apr; 158(8):3721-9. PubMed ID: 9103436
[TBL] [Abstract][Full Text] [Related]
3. The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression.
Blanco J; Valenzuela A; Herrera C; Lluís C; Hovanessian AG; Franco R
FEBS Lett; 2000 Jul; 477(1-2):123-8. PubMed ID: 10899322
[TBL] [Abstract][Full Text] [Related]
4. Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
Martinez-Navio JM; Climent N; Pacheco R; Garcia F; Plana M; Nomdedeu M; Oliva H; Rovira C; Miralles L; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
Immunology; 2009 Nov; 128(3):393-404. PubMed ID: 20067539
[TBL] [Abstract][Full Text] [Related]
5. Comodulation of CXCR4 and CD26 in human lymphocytes.
Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
[TBL] [Abstract][Full Text] [Related]
6. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
7. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.
Ginés S; Mariño M; Mallol J; Canela EI; Morimoto C; Callebaut C; Hovanessian A; Casadó V; Lluis C; Franco R
Biochem J; 2002 Jan; 361(Pt 2):203-9. PubMed ID: 11772392
[TBL] [Abstract][Full Text] [Related]
8. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
9. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
10. Regulation of adenosine receptor engagement by ecto-adenosine deaminase.
Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF
FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704
[TBL] [Abstract][Full Text] [Related]
11. The structure and function of CD26 in the T-cell immune response.
Morimoto C; Schlossman SF
Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
[TBL] [Abstract][Full Text] [Related]
13. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
14. Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.
Gonzalez-Gronow M; Hershfield MS; Arredondo-Vega FX; Pizzo SV
J Biol Chem; 2004 May; 279(20):20993-8. PubMed ID: 15016824
[TBL] [Abstract][Full Text] [Related]
15. Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain.
Beraudi A; Traversa U; Villani L; Sekino Y; Nagy JI; Poli A
Neurochem Int; 2003 May; 42(6):455-64. PubMed ID: 12547644
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
17. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
18. CD26 as a positive regulator of HIV envelope-glycoprotein induced apoptosis in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Adv Exp Med Biol; 1997; 421():207-16. PubMed ID: 9330699
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
20. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
